Issue navigation
Volume 37, Issue Supplement_1, September 2024
ISDE 2024 Congress Supplement - Abstracts submitted to the 20th ISDE World Congress for Esophageal Diseases
Abstracts
198. IDENTIFYING THE OPTIMAL MANAGEMENT OF ESOPHAGEAL ANASTOMOTIC LEAKS. A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.001, https://doi.org/10.1093/dote/doae057.001
199. YOUNGER AGE AS AN INDEPENDENT FACTOR FOR SUBSEQUENT HEAD AND NECK CANCER AFTER CURATIVE ESOPHAGECTOMY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.002, https://doi.org/10.1093/dote/doae057.002
200. THE PENETRATION OF THE THYROID GLAND BY A FISH BONE: A CASE REPORT AND REVIEW OF THE LITERATURE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.003, https://doi.org/10.1093/dote/doae057.003
202. MULTI-ARRAY MIRNA APPROACH AND ASSOCIATED PROTEIN EXPRESSION PROFILING FOR THE DEVELOPMENT OF PREDICTIVE AND PROGNOSTIC BIOMARKERS IN ESOPHAGEAL ADENOCARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.004, https://doi.org/10.1093/dote/doae057.004
203. THE NUMBER OF RESECTED LYMPH NODES FROM THE UPPER MEDIASTINAL AREA PREDICTS LONG-TERM OUTCOMES OF ESOPHAGEAL CANCER AFTER MIE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.005, https://doi.org/10.1093/dote/doae057.005
204. ALTERATIONS IN LOCAL OESOPHAGEAL MICROBIOTA AND OUTCOMES AFTER OESOPHAGECTOMY FOR OESOPHAGO-GASTRIC CANCER: A PILOT STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.006, https://doi.org/10.1093/dote/doae057.006
205. MINIMALLY INVASIVE IVOR LEWIS ESOPHAGECTOMY WITH TOTAL MEDIASTINAL LYMPHADENECTOMY FOR THORACIC ESOPHAGEAL CANCER: SHORT- AND LONG-TERM OUTCOMES IN 139 PATIENTS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.007, https://doi.org/10.1093/dote/doae057.007
212. CLINICAL RESULTS OF PHOTODYNAMIC THERAPY FOR ESOPHAGEAL CANCER PATIENTS WITH INOPERABLE CONDITION
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.008, https://doi.org/10.1093/dote/doae057.008
213. A NEW MANOMETRIC TOOL TO EVALUATE THE EFFICACY OF LAPAROSCOPIC ANTIREFLUX SURGERY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.009, https://doi.org/10.1093/dote/doae057.009
214. THORACIC CAVITY/ CAGE RATIO IS PREDICTOR FOR SURGICAL DIFFICULTY OF MINIMALLY INVASIVE ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.010, https://doi.org/10.1093/dote/doae057.010
215. MALNUTRITION AND VITAMIN DEFICIENCIES AFTER ONCOLOGICAL GASTRIC OR ESOPHAGEAL RESECTION
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.011, https://doi.org/10.1093/dote/doae057.011
220. SHORT-AND LONG-TERM OUTCOMES OF ROBOT ASSISTED MINIMALLY INVASIVE ESOPHAGECTOMY FOR ESOPHAGEAL CANCER: A PROPENSITY SCORE-MATCHED STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.012, https://doi.org/10.1093/dote/doae057.012
222. LONG-TERM SURVIVAL OF ROBOT-ASSISTED ESOPHAGECTOMY AND ITS UTILITY IN TREATING CT4B ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.013, https://doi.org/10.1093/dote/doae057.013
223. OUR SURGICAL TECHNIQUE OF TRACHEAL RESECTION AND ANTERIOR MEDIASTINAL TRACHEOSTOMY (AMT) IN THE MULTIDISCIPLINARY TREATMENT OF ESOPHAGEAL CANCER INVADING TRACHEA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.014, https://doi.org/10.1093/dote/doae057.014
225. LONG-TERM ONCOLOGIC OUTCOMES OF ROBOT-ASSISTED VERSUS CONVENTIONAL OPEN ESOPHAGECTOMY FOR ESOPHAGEAL CANCER: PROPENSITY-SCORE MATCHED ANAYLSIS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.015, https://doi.org/10.1093/dote/doae057.015
226. PHILOSOPHICAL CONSIDERATIONS IN SURGICAL INNOVATION
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.016, https://doi.org/10.1093/dote/doae057.016
227. CAUSES OF IN-HOSPITAL MORTALITY FOLLOWING TRANSTHORACIC ESOPHAGECTOMY FOR CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.017, https://doi.org/10.1093/dote/doae057.017
231. DESCRIBING THE LANDSCAPE OF ESOPHAGECTOMY BETWEEN EASTERN AND WESTERN ESOPHAGEAL SOCIETIES: COMPARATIVE STUDIES FROM THE JAPANESE NCD AND DUTCH DUCA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.018, https://doi.org/10.1093/dote/doae057.018
232. EPIDEMIOLOGY OF EOSINOPHILIC ESOPHAGITIS IN JAPAN: A POPULATION-BASED STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.019, https://doi.org/10.1093/dote/doae057.019
233. UTILITY OF SINGLE TRANSHIATAL CHEST DRAINAGE AFTER MINIMALLY INVASIVE OESOPHAGECTOMY: A PROPENSITY-SCORE MATCHED STUDY OF FEASIBILITY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.020, https://doi.org/10.1093/dote/doae057.020
234. EFFECTS OF TRANSCUTANEOUS ELECTRICAL STIMULATION SYSTEM ON HEARTBURN, REGURGITATION AND ESOPHAGEAL ACID EXPOSURE IN GERD PATIENTS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.021, https://doi.org/10.1093/dote/doae057.021
235. A NOVEL TUMOR STAGING SYSTEM INCORPORATING CN STATUS FOR STRATIFYING EARLY STAGE ESOPHAGEAL SQUAMOUS CELL CARCINOMA PATIENTS AFTER TRIMODAL THERAPY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.022, https://doi.org/10.1093/dote/doae057.022
236. THE ROLE OF ADJUVANT THERAPY FOLLOWING NEOADJUVANT CHEMORADIOTHERAPY AND ESOPHAGECTOMY IN ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.023, https://doi.org/10.1093/dote/doae057.023
237. THE PROGNOSTIC VALUE OF NODAL SKIP METASTASIS IN PATIENTS WITH ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.024, https://doi.org/10.1093/dote/doae057.024
240. CACHEXIA INDEX AS A POTENTIAL BIOMARKER FOR SENSITIVITY OF NEOADJUVANT THERAPY AND PROGNOSIS IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.025, https://doi.org/10.1093/dote/doae057.025
242. BRD4 INHIBITION ENHANCES THE RADIOSENSITIVITY OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA THROUGH REGULATING ATF3-MEDIATED SERINE AND NUCLEOTIDE SYNTHESIS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.026, https://doi.org/10.1093/dote/doae057.026
243. IS MUCOSAL CHANGE IN COELIAC DISEASE RESTRICTED TO SMALL BOWEL? STUDY OF OESOPHAGEAL MUCOSAL CHANGES IN CHILDREN WITH COELIAC DISEASE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.027, https://doi.org/10.1093/dote/doae057.027
245. ESOPHAGECTOMY AFTER NEOADJUVANT CHEMOTHERAPY WITH AN INDICATION FOR CONVERSION SURGERY FOR HIGHLY ADVANCED ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.028, https://doi.org/10.1093/dote/doae057.028
246. EFFECT OF INTRAOPERATIVE NERVE MONITORING DURING MINIMALLY INVASIVE ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.029, https://doi.org/10.1093/dote/doae057.029
247. INVESTIGATION ON THE RECURRENCE AND PROGNOSIS WITH MM/SM1 OESOPHAGEAL SUPERFICIAL CANCER AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.030, https://doi.org/10.1093/dote/doae057.030
249. OVERALL SURVIVAL OF PATIENTS WITH ESOPHAGEAL CANCER TREATED WITH DEFINITIVE CHEMORADIOTHERAPY: INSIGHTS FROM A RETROSPECTIVE STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.031, https://doi.org/10.1093/dote/doae057.031
250. CHANGES IN AND CLINICAL UTILITY OF MAXIMUM PHONATION TIME AND REPETITIVE SALIVA SWALLOWING TEST SCORES AFTER ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.032, https://doi.org/10.1093/dote/doae057.032
251. THE COMPARISON OF UNIPORTAL VERSUS MULTIPORTAL VIDEO-ASSISTED THORACIC SURGERY FOR ESOPHAGEAL CANCER: A PROPENSITY-WEIGHTED ANALYSIS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.033, https://doi.org/10.1093/dote/doae057.033
252. RIGHT GASTROEPIPLOIC ARTERY LENGTH DETERMINED ANASTOMOTIC LEAKRIGHT GASTROEPIPLOIC ARTERY LENGTH DETERMINED ANASTOMOTIC LEAKAGE AFTER MINIMALLY INVASIVE ESOPHAGECTOMY FOR ESOPHAGEAL CANCER-A PROSPECTIVE COHORT STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.034, https://doi.org/10.1093/dote/doae057.034
253. CLINICAL USEFULNESS OF ENDOSCOPY, BARIUM FLUOROSCOPY, AND CHEST COMPUTED TOMOGRAPHY FOR THE CORRECT DIAGNOSIS OF ACHALASIA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.035, https://doi.org/10.1093/dote/doae057.035
254. QUANTIFYING PERIOPERATIVE RISKS FOR ANTIREFLUX AND HIATUS HERNIA SURGERY: A MULTICENTER COHORT STUDY OF 4301 PATIENTS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.036, https://doi.org/10.1093/dote/doae057.036
256. PROGNOSIS AND RISK FACTORS FOR SUPRACLAVICULAR LYMPH NODE METASTASIS IN PATIENTS WITH MIDDLE AND LOWER THORACIC ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.037, https://doi.org/10.1093/dote/doae057.037
258. SHORT-TERM OUTCOMES AFTER ESOPHAGECTOMY ANALYZED USING NATIONAL CLINICAL DATABASE IN JAPAN
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.038, https://doi.org/10.1093/dote/doae057.038
260. LOW BLOOD LEVEL OF TUMOR SUPPRESSOR MIR-3619 AS A TARGET OF NUCLEIC ACID THERAPY TO PIM-1 IN ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.039, https://doi.org/10.1093/dote/doae057.039
261. CONVERSION ESOPHAGECTOMY FOR CT4B ESOPHAGEAL CANCER - MIE VS OPEN -
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.040, https://doi.org/10.1093/dote/doae057.040
262. EOSINOPHILIC ESOPHAGITIS: A SEVEN YEAR ANALYSIS OF EPIDEMIOLOGY IN A UNITED KINGDOM COUNTY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.041, https://doi.org/10.1093/dote/doae057.041
263. LEARNING CURVE ANALYSIS USING CUMULATIVE SUM TECHNIQUES FOR ROBOT-ASSISTED MINIMALLY INVASIVE ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.042, https://doi.org/10.1093/dote/doae057.042
264. SIGNIFICANCE AND USEFULNESS OF PLASMA SUBSTANCE P CONCENTRATION IN PREDICTING HIGH-RISK PATIENTS FOR ASPIRATION AFTER ESOPHAGEAL CANCER SURGERY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.043, https://doi.org/10.1093/dote/doae057.043
265. INITIAL RESULTS FROM RESOLVE, A PHASE 1B DOSE-ESCALATION STUDY OF EP-104GI (EXTENDED-RELEASE FLUTICASONE PROPIONATE INTRA-ESOPHAGEAL INJECTION) FOR EOSINOPHILIC ESOPHAGITIS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.044, https://doi.org/10.1093/dote/doae057.044
266. NSQIP 5-FACTOR MODIFIED FRAILTY INDEX PREDICTS MORBIDITY BUT NOT MORTALITY AFTER ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.045, https://doi.org/10.1093/dote/doae057.045
270. ANALYSIS OF THE RELATIONSHIP BETWEEN CARDIAC DIAMETER AND ANASTOMOTIC TROUBLE IN TRANS HIATAL ESOPHAGOGASTRIC JUNCTION CANCER SURGERY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.046, https://doi.org/10.1093/dote/doae057.046
271. EFFICACY OF NEOADJUVANT CF OR DCF, FLOT PLUS NIVOLUMAB FOR RESECTABLE LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA (JCOG1804E: FRONTIER)
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.047, https://doi.org/10.1093/dote/doae057.047
272. HOSPITAL VARIATION IN PALLIATIVE TREATMENT FOR ESOPHAGEAL AND GASTROESOPHAGEAL JUNCTION CANCER: A NATIONWIDE POPULATION-BASED STUDY IN THE NETHERLANDS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.048, https://doi.org/10.1093/dote/doae057.048
273. PERIOPERATIVE BLOOD TRANSFUSIONS AND SURVIVAL IN GASTROESOPHAGEAL CANCERS – A SWEDISH POPULATION-BASED STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.049, https://doi.org/10.1093/dote/doae057.049
274. ROBOTIC REVISIONAL HIATAL HERNIA REPAIR (R-RHR): DOES IT MAKE SENSE?
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.050, https://doi.org/10.1093/dote/doae057.050
275. SAFETY AND TREATMENT RESULTS OF SELF-EXPANDABLE METAL STENT (SEMS) PLACEMENT FOR ESOPHAGEAL DISEASE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.051, https://doi.org/10.1093/dote/doae057.051
276. AI NAVIGATION SURGERY FOR ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.052, https://doi.org/10.1093/dote/doae057.052
277. FLUORESCENCE-GUIDED ANASTOMOSIS DURING SINGLE-PORT VATS IVOR LEWIS ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.053, https://doi.org/10.1093/dote/doae057.053
278. PROPOSED REVISION TO THE DESCRIPTION OF T3 FOR ESOPHAGEAL CANCER: REMOVAL OF “ADVENTITIA”
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.054, https://doi.org/10.1093/dote/doae057.054
279. NOVEL REFLUX MICROASPIRATION SCINTIGRAPHY ALLOWS EFFECTIVE PATIENT SELECTION FOR ANTIREFLUX SURGERY IN PROXIMAL REFLUX EVENTS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.055, https://doi.org/10.1093/dote/doae057.055
280. MANOMETRIC FINDINGS IN PATIENTS WITH GIANT HIATAL HERNIA: OESOPHAGEAL PHYSIOLOGY APPEARS TO IMPROVE WITH SURGERY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.056, https://doi.org/10.1093/dote/doae057.056
281. PROTEOMIC, TRANSCRIPTOMIC AND GENOMIC ANALYSIS OF ESOPHAGEAL ADENOCARCINOMA UNCOVERS CANDIDATE THERAPEUTIC TARGETS AND CANCER-SELECTIVE POST-TRANSCRIPTIONAL REGULATION
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.057, https://doi.org/10.1093/dote/doae057.057
283. MODIFIED FRAILTY INDEX AND CLINICAL FRAILTY SCALE TOOLS ARE NOT GOOD PREDICTORS OF SURVIVAL AFTER MINIMALLY INVASIVE ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.058, https://doi.org/10.1093/dote/doae057.058
286. TREATMENT WITH CURATIVE INTENT FOR OLIGOMETASTATIC GASTROESOPHAGEAL CANCER-RESULTS OF A PROSPECTIVE MULTICENTER STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.059, https://doi.org/10.1093/dote/doae057.059
289. OUTCOME OF CONVERSION SURGERY FOR ESOPHAGEAL CANCER WITH SYNCHRONOUS ABDOMINAL PARAAORTIC LYMPH NODE METASTASIS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.060, https://doi.org/10.1093/dote/doae057.060
290. EVALUATION OF THE POST-OPERATIVE GERD AND RESIDUAL CHEST PAIN AFTER POEM
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.061, https://doi.org/10.1093/dote/doae057.061
291. CLINICAL OUTCOMES OF IMMUNOCHEMOTHERAPY FOR UNRESECTABLE OR RECURRENT ESOPHAGEAL SQUAMOUS CELL CARCIONOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.062, https://doi.org/10.1093/dote/doae057.062
292. CHEMOTHERAPY AND CHEMORADIOTHERAPY FOR ADENOCARCINOMA OF THE OESOPHAGUS AND JUNCTION WITH OLIGOMETASTASES: RESULTS OF THE TNT-OES-1 TRIAL
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.063, https://doi.org/10.1093/dote/doae057.063
293. OUTCOMES AFTER SURGICAL TREATMENT OF OESOPHAGOGASTRIC CANCER WITH SYNCHRONOUS LIVER METASTASES: A MULTICENTRE RETROSPECTIVE COHORT STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.064, https://doi.org/10.1093/dote/doae057.064
294. LEARNING CURVE OF MINIMALLY INVASIVE ESOPHAGECTOMY: OUR SERIES, SYSTEMATIC REVIEW OF THE LITERATURE AND META-ANALYSIS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.065, https://doi.org/10.1093/dote/doae057.065
295. SAFETY OF SURVEILLANCE GASTROSCOPY AND ENDOSCOPIC ULTRASONOGRAPHY IN THE OESOPHAGUS AFTER NEOADJUVANT CHEMORADIOTHERAPY: RESULTS FROM THE SANO COHORT
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.066, https://doi.org/10.1093/dote/doae057.066
296. CLINICAL T1B-SM2-3N0M0 ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.067, https://doi.org/10.1093/dote/doae057.067
297. ASSESSING BLOOD-BASED BIOMARKERS IN OESOPHAGEAL CANCER PATIENTS RECEIVING NEOADJUVANT CHEMORADIOTHERAPY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.068, https://doi.org/10.1093/dote/doae057.068
299. SURGICAL STRATEGY FOR THE TREATMENT OF AORTOESOPHAGEAL FISTULA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.069, https://doi.org/10.1093/dote/doae057.069
300. SURFACE MICRODIALYSIS MEASURES LOCAL TISSUE METABOLISM AFTER IVOR LEWIS ESOPHAGECTOMY; AN ATTEMPT TO PREDICT ANASTOMOTIC DEFECT
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.070, https://doi.org/10.1093/dote/doae057.070
303. VACUUM-STENT TREATMENT FOR TRANSMURAL DEFECTS IN THE UPPER GASTRO-INTESTINAL TRACT: CASE SERIES AND NEW INSIGHTS IN A TERTIARY REFERRAL CENTER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.071, https://doi.org/10.1093/dote/doae057.071
304. OUTCOMES OF ANASTOMOTIC LEAKAGE AFTER ESOPHAGECTOMY BEFORE AND AFTER IMPLEMENTATION OF ENDOSCOPIC VACUUM THERAPY IN A TERTIARY REFERRAL CENTER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.072, https://doi.org/10.1093/dote/doae057.072
306. TREATMENT OF ANASTOMOTIC LEAKS AFTER ESOPHAGECTOMY AND GASTRECTOMY FOR CANCER BY MEANS OF ENDOSCOPIC VACUUM THERAPY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.073, https://doi.org/10.1093/dote/doae057.073
309. COMPARATIVE OUTCOMES OF OPEN VS. MINIMALLY INVASIVE ESOPHAGECTOMY FOR ESOPHAGEAL AND GASTRO-ESOPHAGEAL JUNCTION TUMORS: INSIGHTS FROM A THORACO-ABDOMINAL STRATIFICATION MODEL
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.074, https://doi.org/10.1093/dote/doae057.074
311. PROGNOSTIC VALUE OF DIFFERENT CIRCUMFERENTIAL MARGIN SITES IN OESOPHAGEAL CANCER: A 10-YEAR COHORT STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.075, https://doi.org/10.1093/dote/doae057.075
312. THE VALUE OF DETECTING THE GASTRIC TUBE PRESSURE AFTER MINIMALLY INVASIVE ESOPHAGECTOMY: A PROSPECTIVE, UNCONTROLLED EXPLORATORY STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.076, https://doi.org/10.1093/dote/doae057.076
313. CLINICAL EVALUATION OF PEMBROLIZUMAB PLUS CISPLATIN AND FLUOROURACIL AS INDUCTION FOR PATIENTS WITH CT4B ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.077, https://doi.org/10.1093/dote/doae057.077
314. TRANSORAL ANTEGRADE T-TUBE INSERTION FOR MANAGEMENT OF OESOPHAGEAL LEAKS FOLLOWING MINIMAL INVASIVE OESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.078, https://doi.org/10.1093/dote/doae057.078
315. SHORT-TERM RESULTS OF ROBOT-ASSISTED SURGERY FOR ESOPHAGEAL CANCER IN JAPAN 5 YEARS AFTER INSURANCE COVERAGE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.079, https://doi.org/10.1093/dote/doae057.079
317. PD-L1 DYNAMICS DURING THE CISPLATIN-INDUCED ACQUIRED RESISTANCE PROCESS IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.080, https://doi.org/10.1093/dote/doae057.080
318. EFFICACY OF PROPHYLACTIC STEROID THERAPY OF INJECTION AND ADMINISTRATION AGAINST STRICTURE FOR SUBENTIRE CIRCUMFERENTIAL DEFECT AFTER ESOPHAGEAL ENDOSCOPIC SUBMUCOSAL DISSECTION
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.081, https://doi.org/10.1093/dote/doae057.081
319. EXTENSIVE LYMPHADENECTOMY MAY IMPROVE SURVIVAL IN NODE NEGATIVE OESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.082, https://doi.org/10.1093/dote/doae057.082
320. RISK FACTORS FOR BENIGN ANASTOMOTIC STENOSIS AFTER ESOPHAGEAL CANCER SURGERY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.083, https://doi.org/10.1093/dote/doae057.083
321. ANASTOMOTIC LEAK WITH ENHANCED RECOVERY PROTOCOL VERSUS CONVENTIONAL CARE AFTER ESOPHAGECTOMY FOR CANCER: CLINICAL CHARACTERISTICS AND OUTCOMES
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.084, https://doi.org/10.1093/dote/doae057.084
322. IMPACT OF POSTOPERATIVE NUTRITIONAL SUPPORT MODES ON CLINICAL AND PATIENT-REPORTED OUTCOMES IN ENHANCED RECOVERY AFTER ESOPHAGECTOMY FOR CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.085, https://doi.org/10.1093/dote/doae057.085
323. LONG-TERM SURVIVAL OUTCOME OF PATIENTS WITH EARLY ESOPHAGEAL CANCER AFTER ESD (ENDOSCOPIC SUBMUCOSAL DISSECTION) AND ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.086, https://doi.org/10.1093/dote/doae057.086
324. A RETROSPECTIVE SINGLE CENTRE PROPENSITY-MATCHED ANALYSIS OF TRANSTHORACIC VERSUS TRANSABDOMINAL PROCEDURES FOR GIANT HIATAL HERNIAS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.087, https://doi.org/10.1093/dote/doae057.087
325. SURGERY FOR EPIPHRENIC ESOPHAGEAL DIVERTICULUM, SHORT AND LONG TERM RESULTS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.088, https://doi.org/10.1093/dote/doae057.088
326. SPONTANEOUS OESOPHAGEAL PERFORATION TREATED WITH OESOPHAGEAL STENT
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.089, https://doi.org/10.1093/dote/doae057.089
327. INCIDENCE OF GASTRIC BAND REMOVAL: A REVIEW OF THE LITERATURE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.090, https://doi.org/10.1093/dote/doae057.090
328. NORMAN RUPERT BARRETT (1903 – 1979)
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.091, https://doi.org/10.1093/dote/doae057.091
329. PREDICTION OF MEDIASTINAL LYMPH NODE METASTASIS IN SIEWERT TYPE I/II ESOPHAGOGASTRIC JUNCTION CANCER WITH ESOPHAGEAL INVASION
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.092, https://doi.org/10.1093/dote/doae057.092
331. CASE-MIX ADJUSTMENT IN BETWEEN-HOSPITAL COMPARISONS ON CLINICAL OUTCOMES IN ESOPHAGEAL AND GASTRIC CANCER SURGERY: A NATIONWIDE POPULATION-BASED COHORT STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.093, https://doi.org/10.1093/dote/doae057.093
332. OUTCOMES OF SALVAGE SURGERY FOR ESOPHAGEAL CARCINOMA: A NATIONWIDE COHORT STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.094, https://doi.org/10.1093/dote/doae057.094
333. TECHNICAL CONSIDERATIONS IN UPPER-GI RECONSTRUCTION – A CASE SERIES
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.095, https://doi.org/10.1093/dote/doae057.095
335. IMPACT OF POSTOPERATIVE COMPLICATIONS ON LONG-TERM OUTCOMES AFTER ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.096, https://doi.org/10.1093/dote/doae057.096
336. EFFICACY AND SAFETY OF PHOTODYNAMIC THERAPY FOR SECONDARY PRIMARY ESOPHAGEAL SQUAMOUS CELL CARCINOMA AFTER CHEMORADIOTHERAPY OR RADIOTHERAPY FOR ANOTHER MALIGNANCY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.097, https://doi.org/10.1093/dote/doae057.097
339. MANAGEMENT OF OESOPHAGO-PLEURAL FISTULAS WITH ENDOSCOPIC VACUUM THERAPY: A PROMISING APPROACH
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.098, https://doi.org/10.1093/dote/doae057.098
340. THE IMPACT OF OBESITY ON SURGICAL OUTCOMES AFTER ESOPHAGECTOMY FOR CANCER IN SWEDEN
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.099, https://doi.org/10.1093/dote/doae057.099
341. EXCISION OF EPIPHRENIC DIVERTICULUM WITH CARDIOMYOTOMY AND FUNDOPLICATION
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.100, https://doi.org/10.1093/dote/doae057.100
342. BILATERAL THORACOSCOPIC APPROACH FOR ADVANCED ESOPHAGEAL CANCER COMPLICATED WITH DOUBLE AORTIC ARCH (DAA)
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.101, https://doi.org/10.1093/dote/doae057.101
343. DIAGNOSTIC VALUE OF ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSESOPHAGEAL NEEDLE ASPIRATION (EBUS-TENA) IN LESIONS ADJACENT TO BOTH THE TRACHEA/BRONCHUS AND ESOPHAGUS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.102, https://doi.org/10.1093/dote/doae057.102
344. SURGICAL APPROACH FOR SPONTANEOUS ESOPHAGEAL RUPTURE: THORACOSCOPY COMBINED WITH GASTROSCOPY AND TRADITIONAL THORACOTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.103, https://doi.org/10.1093/dote/doae057.103
345. PERI-OPERATIVE SELECTIVE DECONTAMINATION OF THE DIGESTIVE TRACT TO PREVENT SEVERE INFECTIOUS COMPLICATIONS AFTER ESOPHAGECTOMY: A RANDOMIZED MULTICENTER CLINICAL TRIAL
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.104, https://doi.org/10.1093/dote/doae057.104
346. ESOPHAGOGASTRIC JUNCTION SIEWERT II TUMORS, A CHALLENGE FOR THE SURGEON: RESULTS OF TRANSHIATAL EXTENDED GASTRECTOMY VS. IVOR LEWIS ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.105, https://doi.org/10.1093/dote/doae057.105
347. THE EFFICACY OF CONVERSION SURGERY IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA WITH INVASION OF OTHER ORGANS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.106, https://doi.org/10.1093/dote/doae057.106
348. MANAGEMENT OF AORTO-ESOPHAGEAL FIFISTULA SECONDARY AFTER THORACIC ENDOVASCULAR AORTIC REPAIR
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.107, https://doi.org/10.1093/dote/doae057.107
349. CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS OF ESOPHAGEAL SPINDLE CELL CARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.108, https://doi.org/10.1093/dote/doae057.108
350. CONTINUOUS INTRAOPERATIVE NERVE MONITORING TO REDUCE THE LEFT RECURRENT LARYNGEAL NERVE PARALYSIS IN TRANSMEDIASTINAL ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.109, https://doi.org/10.1093/dote/doae057.109
351. CONVERSION SURGERY FOR PATIENTS WITH ESOPHAGEAL CANCER AFTER ICI TREATMENT
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.110, https://doi.org/10.1093/dote/doae057.110
352. A RARE CASE OF ESOPHAGEAL EPIDERMOID METAPLASIA: A POTENTIAL PRECURSOR TO ESOPHAGEAL MALIGNANCY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.111, https://doi.org/10.1093/dote/doae057.111
353. INNOVATIVE SURGICAL TECHNIQUES TO REDUCE RECURRENCE IN LAPAROSCOPIC RADICAL TREATMENT OF GIANT HIATAL HERNIA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.112, https://doi.org/10.1093/dote/doae057.112
354. NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY SURGERY VERSUS UPFRONT SURGERY FOR ESOPHAGEAL CANCER: LONG-TERM OUTCOMES IN A CROSS TRIAL STUDY CENTER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.113, https://doi.org/10.1093/dote/doae057.113
355. LONG-TERM RESULTS OF LAPAROSCOPIC HELLER-DOR FOR ESOPHAGO-GASTRIC JUNCTION OUTFLOW OBSTRUCTION: A PROSPECTIVE CONTROLLED TRIAL
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.114, https://doi.org/10.1093/dote/doae057.114
356. TUMOUR BURDEN CORRELATES WITH THE RISK OF RECURRENCE AFTER PIECEMEAL ENDOSCOPIC RESECTION OF EARLY-STAGE ADENOCARCINOMA IN BARRETT’S OESOPHAGUS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.115, https://doi.org/10.1093/dote/doae057.115
357. OUTCOMES OF TWO-COURSE NEOADJUVANT CHEMOTHERAPY WITH DOCETAXEL, CISPLATIN, AND 5-FLUOROURACIL ON ADVANCED ESOPHAGEAL CANCER: A SINGLE INSTITUTION STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.116, https://doi.org/10.1093/dote/doae057.116
358. IMPLICATIONS ON OVERALL SURVIVAL FROM POSITIVE CIRCUMFERENTIAL RESECTION MARGINS IN OESOPHAGEAL CANCER PATIENTS AT A TERTIARY REFERRAL CENTRE IN ENGLAND
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.117, https://doi.org/10.1093/dote/doae057.117
359. INNOVATIVE USE OF WEERDA DIVERTICULOSCOPE FOR REMOVAL OF AN IMPACTED SHARP FOREIGN BODY IN THE CERVICAL OESOPHAGUS MIMICKING MALIGNANCY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.118, https://doi.org/10.1093/dote/doae057.118
360. RECURRENCE PATTERNS AFTER PRIMARY SURGERY AND NEOADJUVANT CHEMORADIOTHERAPY FOR ESOPHAGEAL ADENOCARCINOMA: ACROSS THE CROSS RECURRENCES
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.119, https://doi.org/10.1093/dote/doae057.119
361. PHOTODYNAMIC THERAPY IN THE TREATMENT OF ESOPHAGEAL MUCOSAL METAPLASIA IN CHILDREN
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.120, https://doi.org/10.1093/dote/doae057.120
362. DELAY IN SOLID GASTRIC EMPTYING IS ASSOCIATED WITH SILENT REGURGITATION EVENTS, PULMONARY MICROASPIRATION AND LARYNGOPHARYNGEAL REFLUX DISEASE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.121, https://doi.org/10.1093/dote/doae057.121
363. REFLUX MICRO-ASPIRATION: WHAT HAVE WE LEARNED
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.122, https://doi.org/10.1093/dote/doae057.122
364. IMPROVING PERIOPERATIVE OESOPHAGECTOMY OUTCOMES WITH THE USE OF ROBOTIC SURGERY AT A HIGH VOLUME UK CENTRE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.123, https://doi.org/10.1093/dote/doae057.123
365. METHYLATION BIOMARKERS TO STRATIFY BARRETT’S ESOPHAGUS PATIENTS PROGRESSING AND NON-PROGRESSING TO ESOPHAGEAL ADENOCARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.124, https://doi.org/10.1093/dote/doae057.124
366. MINIMALLY INVASIVE MANAGEMENT OF AORTO-OESOPHAGEAL FISTULA: THORACIC ENDOVASCULAR AORTIC REPAIR AND THORACOSCOPIC ASSISTED OESOPHAGECTOMY WITH DELAYED GASTRIC CONDUIT RECONSTRUCTION
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.125, https://doi.org/10.1093/dote/doae057.125
367. IMPACT OF NEOADJUVANT IMMUNOTHERAPY ON POSTOPERATIVE COMPLICATIONS IN RESECTABLE ESOPHAGEAL ADENOCARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.126, https://doi.org/10.1093/dote/doae057.126
368. THE ROLE OF PG-SGA SCORE IN PREDICTING SHORT- TERM POSTOPERATIVE COMPLICATIONS IN ESOPHAGEAL CANCER SURGERY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.127, https://doi.org/10.1093/dote/doae057.127
369. IMPACT OF THE COVID-19 PANDEMIC ON ESOPHAGEAL CANCER PATIENTS UNDERGOING ESOPHAGECTOMY: AN ACS-NSQIP DATABASE ANALYSIS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.128, https://doi.org/10.1093/dote/doae057.128
370. LOWER MEDIASTINUM DISSECTION IN THORACOSCOPIC ESOPHAGECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.129, https://doi.org/10.1093/dote/doae057.129
371. ENDOFLIP: THE FUTURE OF DYSPHAGIA DIAGNOSIS AND MANAGEMENT
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.130, https://doi.org/10.1093/dote/doae057.130
372. TREATMENT USING NIVO+CHEMO OR NIVO+IPI FOR UNRESECTABLE/RECURRENT ESOPHAGEAL SQUAMOUS CANCER IN OUR INSTITUTE
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.131, https://doi.org/10.1093/dote/doae057.131
373. FLIPPING THE SCRIPT: ENDOFLIPPING THROUGH ESOPHAGEAL CHALLENGES WITH A TWIST!
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.132, https://doi.org/10.1093/dote/doae057.132
374. INCIDENCE AND PREDICTORS OF STRICTURE DEVELOPMENT FOLLOWING ESOPHAGECTOMY: A RETROSPECTIVE ANALYSIS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.133, https://doi.org/10.1093/dote/doae057.133
375. ROLE OF RECURRENTIAL LYMPHADENECTOMY BY MINIMALLY INVASIVE APPROACH IN THE SURGICAL TREATMENT OF ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.134, https://doi.org/10.1093/dote/doae057.134
376. COMPARISON OF POST-SURGICAL NUTRITIONAL STATUS BETWEEN IVOR-LEWIS ESOPHAGECTOMY AND PROXIMAL GASTRECTOMY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.135, https://doi.org/10.1093/dote/doae057.135
378. LAPAROSCOPIC PRIMARY CLOSURE OF ESOPHAGEAL RUPTURE CAUSED BY BALLOON DILATATION FOR ACHALASIA AND HELLER'S MYOTOMY WITH DOR FUNDOPLICATION
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.136, https://doi.org/10.1093/dote/doae057.136
379. SUCCESSFUL MANAGEMENT OF ANASTOMOTIC LEAKAGE FOLLOWING ESOPHAGECTOMY USING ENDO-VACUUM ASSISTED CLOSURE (EVAC) THERAPY: A CASE REPORT
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.137, https://doi.org/10.1093/dote/doae057.137
380. GROWTH CHARACTERISTICS OF ESOPHAGEAL PATIENT DERIVED ORGANOIDS REFLECT CLINICOPATHOLOGIC VARIABLES
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.138, https://doi.org/10.1093/dote/doae057.138
381. MULTICENTER PAN-CANADIAN EXPERIENCE OF PER ORAL ENDOSCOPIC MYOTOMY (POEM) FOR THE TREATMENT OF ACHALASIA: A RETROSPECTIVE STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.139, https://doi.org/10.1093/dote/doae057.139
382. NUMBER OF LYMPH NODES RESECTED IS ASSOCIATED WITH OVERALL SURVIVAL IN PATHOLOGICALLY NODE-NEGATIVE ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.140, https://doi.org/10.1093/dote/doae057.140
383. LOSS OF PERISTALTIC RESERVE DETERMINED BY MULTIPLE RAPID SWALLOWS CORRELATES WITH DYSPHAGIA AND POOR BOLUS TRANSIT IN INEFFECTIVE ESOPHAGEAL MOTILITY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.141, https://doi.org/10.1093/dote/doae057.141
384. NEOADJUVANT ANLOTINIB COMBINED WITH PENPULIMAB FOR RESECTABLE LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC): A PROSPECTIVE, SINGLE-ARM, PHASE II TRIAL
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.142, https://doi.org/10.1093/dote/doae057.142
385. TRANSLATING MOLECULAR-TARGETING FLUORESCENT PROBES IN OESOPHAGEAL CANCER PRE-CLINICAL MODELS
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.143, https://doi.org/10.1093/dote/doae057.143
386. SAFETY AND FEASIBILITY OF PERSONALIZED NEOANTIGEN DC VACCINES IN POSTOPERATIVE ESOPHAGUS SQUAMOUS CELL CARCINOMA: A PHASE 1B TRIAL
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.144, https://doi.org/10.1093/dote/doae057.144
387. VALIDATION OF PROMARKERESO, A DIAGNOSTIC BLOOD TEST TO IDENTIFY ESOPHAGEAL ADENOCARCINOMA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.145, https://doi.org/10.1093/dote/doae057.145
389. WILL SYNCHRONOUS ESOPHAGEAL AND LUNG RESECTION INCREASE THE INCIDENCE OF ANASTOMOTIC LEAKS? A MULTICENTER RETROSPECTIVE STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.146, https://doi.org/10.1093/dote/doae057.146
390. CONTINUED IMPLICATIONS OF THE COVID-19 PANDEMIC ENVIRONMENT ON ESOPHAGEAL CANCER CHARACTERISTICS AND TREATMENT IN THE UNITED STATES
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.147, https://doi.org/10.1093/dote/doae057.147
392. MACHINE LEARNING TO PREDICT LYMPH NODE METASTASIS IN T1 ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A MULTICENTER STUDY
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.148, https://doi.org/10.1093/dote/doae057.148
394. ESOPHAGEAL STENTING IN ESOPHAGEAL CANCER PATIENTS WITH PERFORATION AND FISTULA
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.149, https://doi.org/10.1093/dote/doae057.149
395. SUPERIOR PERFORMANCE OF ROBOT-ASSISTED MINIMALLY INVASIVE ESOPHAGECTOMY OVER THORACOSCOPIC APPROACH: A MULTI-INSTITUTIONAL STUDY ON SHORT-TERM OUTCOMES
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.150, https://doi.org/10.1093/dote/doae057.150
